IL-28, IL-29 and their class II cytokine receptor IL-28R

Paul O. Sheppard, Wayne Kindsvogel(HistoGenetics (United States)), Wenfeng Xu(HistoGenetics (United States)), Katherine Henderson(HistoGenetics (United States)), Stacy Schlutsmeyer(HistoGenetics (United States)), Theodore E. Whitmore(HistoGenetics (United States)), Rolf Kuestner(HistoGenetics (United States)), Ursula Garrigues(HistoGenetics (United States)), Carl Birks(HistoGenetics (United States)), Jenny Roraback(HistoGenetics (United States)), Craig Ostrander(HistoGenetics (United States)), Dennis L Dong(HistoGenetics (United States)), Jinu Shin(HistoGenetics (United States)), Scott Presnell(HistoGenetics (United States)), Brian A. Fox(HistoGenetics (United States)), Betty Haldeman(HistoGenetics (United States)), Emily Cooper(HistoGenetics (United States)), David W. Taft(HistoGenetics (United States)), Teresa Gilbert(HistoGenetics (United States)), Francis James Grant(HistoGenetics (United States)), Monica Tackett(HistoGenetics (United States)), William Krivan(HistoGenetics (United States)), Gary McKnight(HistoGenetics (United States)), Chris Clegg(HistoGenetics (United States)), Don Foster(HistoGenetics (United States)), Kevin Klucher(HistoGenetics (United States))
Nature Immunology
December 2, 2002
10.1038/ni873
Cited by 1,563

Abstract

Related Papers

No related papers found

Powered by citation graph analysis